
    
      -  To test a new approach using allogeneic derived mesenchymal stem cell based therapy
           (MSCT) to treat refractory SSc

        -  To determine the disease-free survival in SSc patients treated with MSCT

        -  To assess adverse events of allogeneic MSC transplantation

        -  To assess the association of remission for organ function, clinical score and SSc
           serology levels at baseline with disease-free survival
    
  